[
  {
    "date": "2023-12-30",
    "symbol": "INZY",
    "period": "FY",
    "netincomeloss": -71169000,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "INOZYME PHARMA, INC.",
    "entitycentralindexkey": 1693011,
    "entityincorporationstatecountrycode": "DE",
    "entityfilenumber": "001-39397",
    "entitytaxidentificationnumber": "38-4024528",
    "entityaddressaddressline1": "321 Summer Street",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2210,
    "cityareacode": 857,
    "localphonenumber": "330-4340",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "INZY",
    "securityexchangename": "NASDAQ",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 42,
    "auditorlocation": "Boston, Massachusetts",
    "auditorname": "Ernst & Young LLP",
    "cashandcashequivalentsatcarryingvalue": 34588000,
    "shortterminvestments": 154001000,
    "prepaidexpenseandotherassetscurrent": 7661000,
    "assetscurrent": 196250000,
    "propertyplantandequipmentnet": 1466000,
    "operatingleaserightofuseasset": 1126000,
    "restrictedcashnoncurrent": 311000,
    "prepaidexpensenoncurrent": 1694000,
    "assets": 200847000,
    "accountspayablecurrent": 1166000,
    "accruedliabilitiescurrent": 12610000,
    "operatingleaseliabilitycurrent": 910000,
    "liabilitiescurrent": 14686000,
    "operatingleaseliabilitynoncurrent": 913000,
    "longtermdebt": 44769000,
    "liabilities": 60368000,
    "commonstockvalue": 6000,
    "additionalpaidincapitalcommonstock": 426362000,
    "accumulatedothercomprehensiveincomelossnetoftax": 41000,
    "retainedearningsaccumulateddeficit": -285930000,
    "stockholdersequity": 140479000,
    "liabilitiesandstockholdersequity": 200847000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 61768771,
    "commonstocksharesoutstanding": 61768771,
    "researchanddevelopmentexpense": 54847000,
    "generalandadministrativeexpense": 20798000,
    "operatingexpenses": 75645000,
    "operatingincomeloss": -75645000,
    "investmentincomeinterest": 7837000,
    "interestexpense": 3333000,
    "othernonoperatingincomeexpense": -28000,
    "nonoperatingincomeexpense": 4476000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": 264000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": -18000,
    "othercomprehensiveincomelossnetoftax": 246000,
    "comprehensiveincomenetoftax": -70923000,
    "earningspersharebasic": -1.37,
    "earningspersharediluted": -1.37,
    "weightedaveragenumberofsharesoutstandingbasic": 51839131,
    "weightedaveragenumberofdilutedsharesoutstanding": 51839131,
    "sharesoutstanding": 61768771,
    "stockissuedduringperiodsharesnewissues": 14375000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7037000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 43209,
    "stockissuedduringperiodvaluesharesissuedinatthemarketoffering": 1000,
    "stockissuedduringperiodsharesissuedinatthemarketoffering": 3553995,
    "issuanceofprefundedwarrantsnetofissuancecosts": 64412000,
    "exerciseofprefundedwarrants": 3325644,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 76560,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 206000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -264000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -18000,
    "profitloss": -71169000,
    "depreciation": 833000,
    "lossondisposaloffixedassets": 20000,
    "sharebasedcompensation": 7037000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 5438000,
    "operatingleaseimpairmentloss": 494000,
    "amortizationofdebtdiscountpremium": 630000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 4134000,
    "increasedecreaseinaccountspayable": -1378000,
    "increasedecreaseinaccruedliabilities": 1255000,
    "increasedecreaseinoperatingleaseliability": -816000,
    "increasedecreaseprepaidexpensesnoncurrent": -2115000,
    "increasedecreaseinothernoncurrentliabilities": -124000,
    "netcashprovidedbyusedinoperatingactivities": -70675000,
    "paymentstoacquiremarketablesecurities": 269330000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 215982000,
    "paymentstoacquirepropertyplantandequipment": 298000,
    "netcashprovidedbyusedininvestingactivities": -53646000,
    "proceedsfromissuanceofcommonstock": 85647000,
    "proceedsfromissuanceoflongtermdebt": 40000000,
    "proceedsfromstockoptionsexercised": 116000,
    "proceedsfromissuanceofcommonstockforcashunderemployeestockpurchaseplan": 206000,
    "netcashprovidedbyusedinfinancingactivities": 125969000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 1648000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -18000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 34899000,
    "restrictedcashandcashequivalents": 311000,
    "interestpaidnet": 2347000,
    "cashcashequivalentsandshortterminvestments": 188600000,
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "emerginggrowthcompanystatusissuanceperiodofnonconvertibledebt": "P3Y",
    "emerginggrowthcompanyannualgrossrevenues": 1235000000,
    "debtsecuritiesheldtomaturitythresholdperiodpastduewriteoff": "P18M",
    "emerginggrowthcompanystatusissuancevalueofnonconvertibledebt": 1000000000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet",
    "operatingleaseliability": 700000,
    "investmentmaturityperiod": "1 year or less",
    "availableforsaledebtsecuritiesamortizedcostbasis": 80160000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 59000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "availableforsalesecuritiesdebtsecurities": 80218000,
    "depreciationandamortization": 800000,
    "interestreceivablecurrent": 385000,
    "prepaidinsurance": 1067000,
    "prepaidresearchstudies": 5339000,
    "otherprepaidexpensecurrent": 870000,
    "propertyplantandequipmentgross": 947000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2413000,
    "employeerelatedliabilitiescurrent": 3838000,
    "accruedprofessionalfeescurrent": 1377000,
    "clinicalexpenses": 3595000,
    "accruedresearchanddevelopmentcostscurrent": 2917000,
    "otheraccruedliabilitiescurrent": 883000,
    "cashandcashequivalentsfairvaluedisclosure": 33830000,
    "assetsfairvaluedisclosure": 73783000,
    "partialupfrontconsiderationpaymentunderlicenseagreement": 100000,
    "costmaintenance": 100000,
    "licenseagreementpaymentuponachievementofspecifiedproductsalesordevelopmentandcommercializationmilestones": 3000000,
    "areaofleasedspace": 8499,
    "lesseeoperatingleaseexpirationyear": 2025,
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseoptiontoextend": "option to extend the term for five years.",
    "lesseeoperatingleaserenewalterm": "P5Y",
    "securitydeposit": 300000,
    "operatingleaseweightedaverageincrementalborrowingrate": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y10M24D",
    "operatingleaseexpense": 900000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1016000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 944000,
    "lesseeoperatingleaseliabilitypaymentdue": 1960000,
    "lineofcreditfacilityunusedcapacitycommitmentfeepercentage": 0.05,
    "debtinstrumentinterestratebasisforeffectiverate": 9.6,
    "debtinstrumentcarryingamount": 45000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 231000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 14508000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 33305000,
    "longtermdebtmaturinginyearstwoandthree": 47813000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3325762,
    "saleofstocknumberofsharesissuedintransaction": 3553995,
    "proceedsfromissuanceorsaleofequity": 21200000,
    "commonstockcapitalsharesreservedforfutureissuance": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "On July 17, 2020, the Company’s stockholders approved the 2020 Stock Incentive Plan (the “2020 Plan”), which became effective on July 23, 2020. The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock units, and other stock-based awards. The number of shares of the Company’s common stock reserved for issuance under the 2020 Plan",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 3325644,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3019590,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 11600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition2": "P3Y2M12D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7036666,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 7600000,
    "allocatedsharebasedcompensationexpense": 7000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 627526,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3370210,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7036666,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.68,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y8M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y4M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y8M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4615000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3007000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 4615000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0336,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0467,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.8726,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8967,
    "deferredtaxassetsvaluationallowance": 88906000,
    "valuationallowancedeferredtaxassetchangeinamount": 26400000,
    "operatinglosscarryforwards": 164500000,
    "operatinglosscarryforwardswithexpirationperiod": 5600000,
    "operatinglosscarryforwardswithnoexpirationperiod": 158900000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 17300000,
    "taxcreditcarryforwardexpirationyear": 2038,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.01,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.081,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.091,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.372,
    "deferredtaxassetsoperatinglosscarryforwards": 42999000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 16903000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1930000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 916000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsamortization": 3759000,
    "leaseincentivereceivable": 499000,
    "deferredtaxassetsinprocessresearchanddevelopment": 21959000,
    "deferredtaxassetsother": 351000,
    "deferredtaxassetsgross": 89316000,
    "deferredtaxassetsnet": 410000,
    "deferredtaxliabilitiespropertyplantandequipment": 64000,
    "deferredtaxliabilitiesrightofuseassets": -308000,
    "others": -38000,
    "deferredincometaxliabilities": 410000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7036666,
    "definedcontributionplanemployerdiscretionarycontributionamount": 300000
  },
  {
    "date": "2022-12-30",
    "symbol": "INZY",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "INOZYME PHARMA, INC.",
    "entitycentralindexkey": 1693011,
    "entityincorporationstatecountrycode": "Delaware",
    "entityfilenumber": "001-39397",
    "entitytaxidentificationnumber": "38-4024528",
    "entityaddressaddressline1": "321 Summer Street",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2210,
    "cityareacode": 857,
    "localphonenumber": "330-4340",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "INZY",
    "securityexchangename": "Nasdaq Global Select Market",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes ",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": " ☐ ",
    "auditorfirmid": 42,
    "auditorlocation": "Boston, Massachusetts",
    "auditorname": "Ernst & Young LLP",
    "cashandcashequivalentsatcarryingvalue": 32915000,
    "shortterminvestments": 94951000,
    "prepaidexpenseandotherassetscurrent": 3527000,
    "assetscurrent": 131393000,
    "propertyplantandequipmentnet": 2018000,
    "operatingleaserightofuseasset": 1620000,
    "otherassetsnoncurrent": 354000,
    "prepaidexpensenoncurrent": 3810000,
    "assets": 139195000,
    "accountspayablecurrent": 2544000,
    "accruedliabilitiescurrent": 11355000,
    "operatingleaseliabilitycurrent": 816000,
    "liabilitiescurrent": 14715000,
    "operatingleaseliabilitynoncurrent": 1823000,
    "longtermdebt": 5312000,
    "otherliabilitiesnoncurrent": 124000,
    "liabilities": 20801000,
    "commonstockvalue": 4000,
    "additionalpaidincapitalcommonstock": 333356000,
    "accumulatedothercomprehensiveincomelossnetoftax": -205000,
    "retainedearningsaccumulateddeficit": -214761000,
    "stockholdersequity": -214761000,
    "liabilitiesandstockholdersequity": 139195000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 100000,
    "generalandadministrativeexpense": 20826000,
    "operatingexpenses": 68675000,
    "operatingincomeloss": -68675000,
    "investmentincomeinterest": 1933000,
    "othernonoperatingincomeexpense": -319000,
    "nonoperatingincomeexpense": 1614000,
    "netincomeloss": -67061000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -198000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": -25000,
    "othercomprehensiveincomelossnetoftax": -223000,
    "comprehensiveincomenetoftax": -67284000,
    "earningspersharebasic": -1.78,
    "earningspersharediluted": -1.78,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7672000,
    "stockissuedduringperiodvaluestockoptionsexercised": 359000,
    "stockissuedduringperiodsharesstockoptionsexercised": 210977,
    "stockissuedduringperiodvaluenewissues": 56137000,
    "issuanceofprefundedwarrantsnetofissuancecosts": 12150000,
    "exerciseofprefundedwarrants": 197240,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 40412,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 92000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -198000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -25000,
    "profitloss": -67061000,
    "depreciation": 744000,
    "gainlossonsaleofpropertyplantequipment": -17000,
    "sharebasedcompensation": 7672000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 1671000,
    "operatingleaseimpairmentloss": 433000,
    "amortizationofdebtdiscountpremium": 93000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -14000,
    "increasedecreaseinaccountspayable": 150000,
    "increasedecreaseinaccruedliabilities": 2857000,
    "increasedecreaseinoperatingleaseliability": -732000,
    "increasedecreaseprepaidexpensesnoncurrent": 401000,
    "increasedecreaseinothernoncurrentliabilities": 124000,
    "netcashprovidedbyusedinoperatingactivities": -57761000,
    "paymentstoacquiremarketablesecurities": 151993000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 147000000,
    "paymentstoacquirepropertyplantandequipment": 410000,
    "netcashprovidedbyusedininvestingactivities": -5403000,
    "proceedsfromissuanceofcommonstock": 56137000,
    "proceedsfromissuanceofwarrants": 12150000,
    "proceedsfromissuanceoflongtermdebt": 4050000,
    "proceedsfromstockoptionsexercised": 359000,
    "proceedsfromissuanceofcommonstockforcashunderemployeestockpurchaseplan": 92000,
    "netcashprovidedbyusedinfinancingactivities": 72788000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 9624000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -25000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 33269000,
    "restrictedcashandcashequivalents": 354000,
    "capitalexpendituresincurredbutnotyetpaid": 14000,
    "interestpaidnet": 170000,
    "cashcashequivalentsandshortterminvestments": 127900000,
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "foreigncurrencytransactiongainlossrealized": 18000,
    "emerginggrowthcompanystatusissuanceperiodofnonconvertibledebt": "three-year",
    "emerginggrowthcompanyannualgrossrevenues": 1235000000,
    "debtsecuritiesheldtomaturitythresholdperiodpastduewriteoff": 12,
    "emerginggrowthcompanystatusissuancevalueofnonconvertibledebt": 1000000000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Lesser of asset life or lease term",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "investmentmaturityperiod": "1 year or less",
    "availableforsaledebtsecuritiesamortizedcostbasis": 95149000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 4000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 202000,
    "availableforsalesecuritiesdebtsecurities": 94951000,
    "depreciationandamortization": 744000,
    "restrictedcash": 400000,
    "interestreceivablecurrent": 115000,
    "prepaidinsurance": 1293000,
    "prepaidresearchstudies": 1397000,
    "otherprepaidexpensecurrent": 722000,
    "prepaidclinicaltrialandother": 3810000,
    "propertyplantandequipmentgross": 3750000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1732000,
    "employeerelatedliabilitiescurrent": 2799000,
    "accruedprofessionalfeescurrent": 746000,
    "accruedresearchanddevelopmentcostscurrent": 7066000,
    "otheraccruedliabilitiescurrent": 744000,
    "cashandcashequivalentsfairvaluedisclosure": 26587000,
    "assetsfairvaluedisclosure": 78336000,
    "partialupfrontconsiderationpaymentunderlicenseagreement": 100000,
    "costmaintenance": 100000,
    "licenseagreementpaymentuponachievementofspecifiedproductsalesordevelopmentandcommercializationmilestones": 3000000,
    "areaofleasedspace": 6244,
    "lesseeoperatingleaseexpirationyear": 2025,
    "lesseeoperatingleaseexistenceofoptiontoextend": "extend",
    "lesseeoperatingleaseoptiontoextend": "option to extend the term for five years",
    "lesseeoperatingleaserenewalterm": "five years",
    "securitydeposit": 400000,
    "operatingleaseweightedaverageincrementalborrowingrate": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": 2.9,
    "operatingleasepayments": 900000,
    "operatingleaseexpense": 700000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 992000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1016000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 944000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2952000,
    "lineofcreditfacilityunusedcapacitycommitmentfeepercentage": 0.05,
    "debtinstrumentcarryingamount": 5000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": -861000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 1617000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 3695000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 197251,
    "commonstockcapitalsharesreservedforfutureissuance": 40412,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "On July 17, 2020, the Company’s stockholders approved the 2020 Stock Incentive Plan (the “2020 Plan”), which became effective on July 23, 2020.  The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The number of shares of the Company’s common stock reserved for issuance under the 2020 Plan",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 197240,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 11800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 9000000,
    "allocatedsharebasedcompensationexpense": 7700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 556394,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.53,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 11.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 9.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 8.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 8.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 18000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 18000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 18000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0159,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.043,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.845,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8715,
    "deferredtaxassetsvaluationallowance": 62468000,
    "valuationallowancedeferredtaxassetchangeinamount": 20400000,
    "operatinglosscarryforwards": 108800000,
    "operatinglosscarryforwardswithexpirationperiod": 5600000,
    "operatinglosscarryforwardswithnoexpirationperiod": 134199999.99999999,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 9400000,
    "taxcreditcarryforwardexpirationyear": 2042,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.016,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.054000000000000006,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.055,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.303,
    "deferredtaxassetsoperatinglosscarryforwards": 36144000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 9220000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1604000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 758000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsamortization": 3899000,
    "leaseincentivereceivable": 688000,
    "deferredtaxassetsinprocessresearchanddevelopment": 10467000,
    "deferredtaxassetsother": 297000,
    "deferredtaxassetsgross": 63077000,
    "deferredtaxassetsnet": 609000,
    "deferredtaxliabilitiespropertyplantandequipment": 184000,
    "deferredtaxliabilitiesrightofuseassets": -422000,
    "others": -3000,
    "deferredincometaxliabilities": 609000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "definedcontributionplanemployerdiscretionarycontributionamount": 300000
  },
  {
    "date": "2021-12-30",
    "symbol": "INZY",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "INOZYME PHARMA, INC.",
    "entitycentralindexkey": 1693011,
    "entityincorporationstatecountrycode": "Delaware",
    "entityfilenumber": "001-39397",
    "entitytaxidentificationnumber": "38-4024528",
    "entityaddressaddressline1": "321 Summer Street",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2210,
    "cityareacode": 857,
    "localphonenumber": "330-4340",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "INZY",
    "securityexchangename": "Nasdaq Global Select Market",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes ",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 42,
    "auditorlocation": "Boston, Massachusetts",
    "auditorname": "Ernst & Young LLP",
    "cashandcashequivalentsatcarryingvalue": 23316000,
    "shortterminvestments": 88485000,
    "prepaidexpenseandotherassetscurrent": 3541000,
    "assetscurrent": 115342000,
    "propertyplantandequipmentnet": 2383000,
    "operatingleaserightofuseasset": 2053000,
    "restrictedcashnoncurrent": 354000,
    "prepaidexpensenoncurrent": 3409000,
    "assets": 123541000,
    "accountspayablecurrent": 2394000,
    "accruedliabilitiescurrent": 8508000,
    "operatingleaseliabilitycurrent": 731000,
    "liabilitiescurrent": 11633000,
    "operatingleaseliabilitynoncurrent": 2640000,
    "liabilities": 14273000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 256948000,
    "accumulatedothercomprehensiveincomelossnetoftax": 18000,
    "retainedearningsaccumulateddeficit": -147700000,
    "stockholdersequity": -147700000,
    "liabilitiesandstockholdersequity": 123541000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 500000,
    "generalandadministrativeexpense": 18926000,
    "operatingexpenses": 56646000,
    "operatingincomeloss": -56646000,
    "investmentincomeinterest": 211000,
    "othernonoperatingincomeexpense": -189000,
    "nonoperatingincomeexpense": 22000,
    "netincomeloss": -56624000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -4000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentbeforetax": 20000,
    "othercomprehensiveincomelossnetoftax": 16000,
    "comprehensiveincomenetoftax": -56608000,
    "earningspersharebasicanddiluted": -2.4,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7164000,
    "stockissuedduringperiodvaluestockoptionsexercised": 609000,
    "stockissuedduringperiodsharesstockoptionsexercised": 283778,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -4000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": 20000,
    "profitloss": -56624000,
    "depreciation": 674000,
    "sharebasedcompensation": 7164000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -170000,
    "operatingleaseimpairmentloss": 378000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 259000,
    "increasedecreaseinaccountspayable": -675000,
    "increasedecreaseinaccruedliabilities": 1871000,
    "increasedecreaseinoperatingleaseliability": -626000,
    "increasedecreaseprepaidexpensesnoncurrent": 226000,
    "netcashprovidedbyusedinoperatingactivities": -48153000,
    "paymentstoacquiremarketablesecurities": 121967000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 165160000,
    "paymentstoacquirepropertyplantandequipment": 397000,
    "netcashprovidedbyusedininvestingactivities": 42796000,
    "proceedsfromstockoptionsexercised": 609000,
    "netcashprovidedbyusedinfinancingactivities": 609000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -4748000,
    "effectofexchangerateoncashandcashequivalents": 24000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 23670000,
    "restrictedcashandcashequivalents": 354000,
    "capitalexpendituresincurredbutnotyetpaid": 12000,
    "rightofuseassetownedatadoption": 2431000,
    "operatingleaseliabilitiesincurredatadoption": 3997000,
    "cashcashequivalentsandshortterminvestments": 111800000,
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "foreigncurrencytransactiongainlossrealized": -26000,
    "emerginggrowthcompanystatusissuanceperiodofnonconvertibledebt": "three-year",
    "emerginggrowthcompanyannualgrossrevenues": 1070000000.0000001,
    "debtsecuritiesheldtomaturitythresholdperiodpastduewriteoff": 12,
    "emerginggrowthcompanystatusissuancevalueofnonconvertibledebt": 1000000000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Lesser of asset life or lease term",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "accountingstandardsupdateextensiblelist": "http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201813Member",
    "investmentmaturityperiod": "1 year or less",
    "availableforsaledebtsecuritiesamortizedcostbasis": 88483000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 5000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 3000,
    "availableforsalesecuritiesdebtsecurities": 88485000,
    "depreciationandamortization": 674000,
    "interestreceivablecurrent": 62000,
    "prepaidinsurance": 1728000,
    "prepaidresearchstudies": 1190000,
    "otherprepaidexpensecurrent": 561000,
    "prepaidclinicaltrialandother": 3409000,
    "propertyplantandequipmentgross": 3384000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1001000,
    "employeerelatedliabilitiescurrent": 2379000,
    "accruedprofessionalfeescurrent": 727000,
    "accruedresearchanddevelopmentcostscurrent": 5066000,
    "otheraccruedliabilitiescurrent": 336000,
    "cashandcashequivalentsfairvaluedisclosure": 14302000,
    "assetsfairvaluedisclosure": 83459000,
    "partialupfrontconsiderationpaymentunderlicenseagreement": 60000,
    "costmaintenance": 100000,
    "licenseagreementpaymentuponachievementofspecifiedproductsalesordevelopmentandcommercializationmilestones": 250000,
    "lesseeoperatingleaseoptiontoextend": "option to extend the term for five years",
    "securitydeposit": 354000,
    "operatingleaseweightedaverageincrementalborrowingrate": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": 3.9,
    "operatingleasepayments": 900000,
    "operatingleaseexpense": 700000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 968000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 992000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1016000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 944000,
    "lesseeoperatingleaseliabilitypaymentsdue": 3920000,
    "commonstockcapitalsharesreservedforfutureissuance": 904016,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "On July 17, 2020, the Company’s stockholders approved the 2020 Stock Incentive Plan (the “2020 Plan”), which became effective on July 23, 2020.  The 2020 Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The number of shares of the Company’s common stock reserved for issuance under the 2020 Plan",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 17.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 12.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 3000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 19300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 6500000,
    "allocatedsharebasedcompensationexpense": 1600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 512570,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.63,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 12.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 10.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 8.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 7428000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 4816000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 7428000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0048,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013700000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.8841,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.9119,
    "deferredtaxassetsvaluationallowance": 42056000,
    "valuationallowancedeferredtaxassetchangeinamount": 17900000,
    "operatinglosscarryforwards": 92000000,
    "operatinglosscarryforwardswithexpirationperiod": 5600000,
    "operatinglosscarryforwardswithnoexpirationperiod": 115700000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 5400000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.016,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.054000000000000006,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.068,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.316,
    "deferredtaxassetsoperatinglosscarryforwards": 31110000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 5268000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 833000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 490000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsamortization": 4194000,
    "leaseincentivereceivable": 875000,
    "deferredtaxassetsother": 96000,
    "deferredtaxassetsgross": 42866000,
    "deferredtaxassetsnet": 810000,
    "deferredtaxliabilitiespropertyplantandequipment": 277000,
    "deferredtaxliabilitiesrightofuseassets": -533000,
    "deferredincometaxliabilities": 810000,
    "managementfeeexpense": 400000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "definedcontributionplanemployerdiscretionarycontributionamount": 221000
  },
  {
    "date": "2020-12-30",
    "symbol": "INZY",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Inozyme Pharma, Inc.",
    "entitycentralindexkey": 1693011,
    "entityincorporationstatecountrycode": "DE",
    "entityfilenumber": "001-39397",
    "entitytaxidentificationnumber": "38-4024528",
    "entityaddressaddressline1": "321 Summer Street",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2210,
    "cityareacode": 857,
    "localphonenumber": "330-4340",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "INZY",
    "securityexchangename": "NASDAQ",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "cashandcashequivalentsatcarryingvalue": 28040000,
    "shortterminvestments": 119657000,
    "prepaidexpenseandotherassetscurrent": 3282000,
    "assetscurrent": 150979000,
    "propertyplantandequipmentnet": 2648000,
    "restrictedcashnoncurrent": 354000,
    "longterminvestments": 12199000,
    "prepaidexpensenoncurrent": 3183000,
    "assets": 169363000,
    "accountspayablecurrent": 3069000,
    "accruedliabilitiescurrent": 6904000,
    "liabilitiescurrent": 9973000,
    "deferredleaseobligations": 1287000,
    "liabilities": 11260000,
    "commonstockvalue": 2000,
    "additionalpaidincapitalcommonstock": 249175000,
    "accumulatedothercomprehensiveincomelossnetoftax": 2000,
    "retainedearningsaccumulateddeficit": -91076000,
    "stockholdersequity": -91076000,
    "liabilitiesandstockholdersequity": 169363000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 23384969,
    "commonstocksharesoutstanding": 23384969,
    "researchanddevelopmentexpense": 400000,
    "generalandadministrativeexpense": 10548000,
    "operatingexpenses": 57041000,
    "operatingincomeloss": -57041000,
    "investmentincomeinterest": 370000,
    "othernonoperatingincomeexpense": 247000,
    "nonoperatingincomeexpense": 617000,
    "netincomeloss": -56424000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodbeforetax": -3000,
    "othercomprehensiveincomelossnetoftax": -3000,
    "comprehensiveincomenetoftax": -56427000,
    "earningspersharebasicanddiluted": -5.11,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11036500,
    "sharesoutstanding": 23384969,
    "temporaryequitystockissuedduringperiodvaluenewissues": 33638000,
    "temporaryequitystockissuedduringperiodsharenewissues": 23566431,
    "temporaryequitystockissuedduringperiodvaluetoacquireinprocessresearchanddevelopment": 17759000,
    "temporaryequitystockissuedduringperiodsharestoacquireinprocessresearchanddevelopment": 8294360,
    "stockissuedduringperiodvaluenewissues": 115915000,
    "stockissuedduringperiodsharesnewissues": 8050000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 129324000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 13953850,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2308000,
    "stockissuedduringperiodvaluestockoptionsexercised": 202000,
    "stockissuedduringperiodsharesstockoptionsexercised": 176489,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -3000,
    "paymentsofstockissuancecosts": 3900000,
    "profitloss": -56424000,
    "depreciationandamortization": 217000,
    "researchanddevelopmentinprocess": 17759000,
    "sharebasedcompensation": 2308000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -277000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2954000,
    "increasedecreaseinaccountspayable": 2098000,
    "increasedecreaseinaccruedliabilities": 3928000,
    "increasedecreaseinotheroperatingassets": 3183000,
    "netcashprovidedbyusedinoperatingactivities": -35974000,
    "paymentstoacquiremarketablesecurities": 177922000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 61311000,
    "paymentstoacquirepropertyplantandequipment": 568000,
    "netcashprovidedbyusedininvestingactivities": -117179000,
    "proceedsfromissuanceofconvertiblepreferredstock": 33638000,
    "proceedsfromstockoptionsexercised": 202000,
    "proceedsfromissuanceinitialpublicoffering": 115972000,
    "netcashprovidedbyusedinfinancingactivities": 149812000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -3341000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 28394000,
    "restrictedcashandcashequivalents": 354000,
    "stockissued1": 17759000,
    "capitalexpendituresincurredbutnotyetpaid": 605000,
    "deferredofferingcostsinaccruedexpenses": 57000,
    "noncashdeferredleaseobligations": 1394000,
    "cashcashequivalentsandshorttermandlongterminvestments": 159900000,
    "concentrationriskcreditriskfinancialinstrumentsoffbalancesheetrisk": "The Company has no significant off-balance sheet risk such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "foreigncurrencytransactiongainlossrealized": 247000,
    "emerginggrowthcompanyannualgrossrevenues": 1070000000,
    "emerginggrowthcompanystatusissuancevalueofnonconvertibledebt": 1000000000,
    "emerginggrowthcompanystatusissuanceperiodofnonconvertibledebt": "P3Y",
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of asset life or lease term",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "accountingstandardsupdateextensiblelist": "us-gaap:AccountingStandardsUpdate201813Member",
    "investmentmaturityperiod": "After 1 year through 5 years",
    "availableforsaledebtsecuritiesamortizedcostbasis": 12198000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 1000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 7000,
    "availableforsalesecuritiesdebtsecurities": 12199000,
    "interestreceivablecurrent": 155000,
    "prepaidinsurance": 1723000,
    "prepaidresearchstudies": 804000,
    "otherprepaidexpensecurrent": 600000,
    "prepaidclinicaltrialandother": 3183000,
    "propertyplantandequipmentgross": 2975000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 327000,
    "employeerelatedliabilitiescurrent": 2296000,
    "accruedprofessionalfeescurrent": 454000,
    "accruedresearchanddevelopmentcostscurrent": 2997000,
    "deferredrentcreditcurrent": 279000,
    "otheraccruedliabilitiescurrent": 878000,
    "cashandcashequivalentsfairvaluedisclosure": 15739000,
    "assetsfairvaluedisclosure": 115115000,
    "partialupfrontconsiderationpaymentunderlicenseagreement": 60000,
    "costmaintenance": 44000,
    "licenseagreementpaymentuponachievementofspecifiedproductsalesordevelopmentandcommercializationmilestones": 3000000,
    "securitydeposit": 130000,
    "lesseeoperatingleaseoptiontoextend": "The Company has the option to extend the term of this lease for a term of five years.",
    "operatingleaseexpense": 654000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 979000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 968000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 992000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1016000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 944000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4899000,
    "commonstockcapitalsharesreservedforfutureissuance": 568235,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1588315,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1628265,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 12.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 700000,
    "allocatedsharebasedcompensationexpense": 500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 13900,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3064457,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 22746,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 835769,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 3064457,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.28,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.12,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 7.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y9M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y9M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 41680000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 15070000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 41680000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0036,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0055,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y9M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.8654,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.9985,
    "operatinglosscarryforwards": 50400000,
    "operatinglosscarryforwardswithexpirationperiod": 5600000,
    "operatinglosscarryforwardswithnoexpirationperiod": 64000000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "deferredtaxassetsvaluationallowance": 24199000,
    "valuationallowancedeferredtaxassetchangeinamount": 14900000,
    "taxcreditcarryforwardamount": 1000000,
    "taxcreditcarryforwardexpirationyear": 2040,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.005,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.05,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.009,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.264,
    "deferredtaxassetsoperatinglosscarryforwards": 17712000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1007000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 157000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 594000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 408000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsamortization": 4520000,
    "deferredtaxassetsother": 173000,
    "deferredtaxassetsgross": 24571000,
    "deferredtaxassetsnet": 372000,
    "deferredtaxliabilitiespropertyplantandequipment": 372000,
    "deferredincometaxliabilities": 372000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3064457,
    "acquisitionintellectualpropertyresearchanddevelopmentexpenses": 17900000
  }
]